Vasudha Sehgal
Moderna Therapeutics (United States)(US)
Publications by Year
Research Areas
MicroRNA in disease regulation, Cancer, Stress, Anesthesia, and Immune Response, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, PI3K/AKT/mTOR signaling in cancer
Most-Cited Works
- → Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study(2024)641 cited
- → Tumour angiogenesis regulation by the miR-200 family(2013)413 cited
- → Hematogenous Metastasis of Ovarian Cancer: Rethinking Mode of Spread(2014)320 cited
- → Inhibition of mTORC1/2 Overcomes Resistance to MAPK Pathway Inhibitors Mediated by PGC1α and Oxidative Phosphorylation in Melanoma(2014)200 cited
- → A switch in the source of ATP production and a loss in capacity to perform glycolysis are hallmarks of hepatocyte failure in advance liver disease(2014)141 cited
- → 2′-OMe-phosphorodithioate-modified siRNAs show increased loading into the RISC complex and enhanced anti-tumour activity(2014)134 cited
- → Sustained Adrenergic Signaling Promotes Intratumoral Innervation through BDNF Induction(2018)127 cited
- → Cupid: simultaneous reconstruction of microRNA-target and ceRNA networks(2014)110 cited
- → Adrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian Cancer(2015)91 cited
- → Notch3 Pathway Alterations in Ovarian Cancer(2014)70 cited